SHW
The Sherwin-Williams Company
$336.01
+1.33% 2026-10-20
MaterialsS&P 500
SHWSPY
1W
+3.7%
1M
+4.8%
3M
+5.8%
6M
+0.9%
YTD
+4.4%
1Y
+2.4%
Live chart
Loading live chart…
Grades vs sector
Momentum25th pct in sectorD+
Momentum
25th pct in sector
12-1 return: -5.4%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth46th pct in sectorC
Growth
46th pct in sector
Revenue growth (YoY): +7.5%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value11th pct in sectorD-
Value
11th pct in sector
Forward E/P: 4.0% · EBITDA/EV: 4.9%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability89th pct in sectorA
Profitability
89th pct in sector
Profit margin: +11.0% · Return on equity: +65.1%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
rank 90 of 360 · Composite (0-1) 0.6
Momentum Top 15rank 346 of 499 · 12-1 momentum % -1.2
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsHow Bad Would Shrinking Store Sales Be For Lowe's Stock?
Trefis · 17h ago
Sherwin-Williams (SHW) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · 21h ago
These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech
Investopedia · Oct 15
The One Thing To Settle Before Buying RPM Stock
Trefis · Oct 14
What Could Derail Lowe's Stock?
Trefis · Oct 14
Key stats
Market cap$81.6B
P/E (trailing)31.0
P/E (forward)24.9
52-week range289.86 – 377.77
Revenue growth (YoY, latest qtr)+7.5%
Dividend yield0.97%
Analyst consensusBuy (24)
Mean price target$383.12 (+14%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Looks expensive
Model read-out from the numbers below, not advice. Score -3 (DCF counts double).
▼DCF (base case)below the price by 51%
▼Forward P/E vs sector24.9x vs median 12.7x
•Piotroski F-score6/9
•Net debt / EBITDA2.7x
•Analyst target+14% (24 analysts)
Discounted cash flow
CyclicalValued on average-cycle margins
Specialty Chemicals profits swing with the business cycle, so one year's cash flow can be far above or below normal. Instead of the last 12 months' free cash flow (3.7B, a 15% margin), the DCF and reverse DCF use the average free-cash-flow margin over FY2016–FY2025 (10 years: 13.0%) times current revenue = 3.2B. On trailing cash flow the base case would be $202; on mid-cycle cash flow it is $164. Glossary
Bear
$88
-74%
growth -0% · disc. 10.7% · term. 2.0%
Base
$164
-51%
growth 5% · disc. 9.7% · term. 2.5%
Bull
$264
-21%
growth 8% · disc. 8.7% · term. 3.0%
Starting cash flow is mid-cycle: 13.0% average margin × current revenue = 3.2B (last 12 months: 3.7B at a 15% margin). On trailing cash flow the base case would be $202.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 12% a year for 10 years.
Implied
+12%/yr
FCF, last 3 yrs
+22%/yr
FCF, last 5 yrs
+0%/yr
Revenue, last 3 yrs
+2%/yr
Revenue, last 5 yrs
+5%/yr
Same inputs as the DCF above: mid-cycle free cash flow 3.2B, 9.7% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.08 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
P/E (trailing)
pricier
sector median 20.6× · 71st pct
31.0×pricier
Forward P/E
pricier
sector median 12.7× · 88th pct
24.9×pricier
EV / EBITDA
pricier
sector median 11.1× · 95th pct
21.2×pricier
Price / sales
pricier
sector median 1.4× · 79th pct
3.3×pricier
Price / book
pricier
sector median 2.3× · 99th pct
21.2×pricier
FCF yield
pricier
sector median 4.7% · 48th pct
4.6%pricier
Forward EPS $13.51 vs trailing $10.85 (+25% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
49.0%
Operating margin
18.1%
FCF margin
15.3%
Net margin
11.0%
Return on equity
69.7%
Return on invested capital
21.7%
Net debt / EBITDA
2.7×
Current ratio
0.7×
Interest cover
8.5×
Cash conversion (OCF/NI)
1.4×
Piotroski F-score 6/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✓ Gross margin improved✗ Asset turnover improved
Analysts
Mean target
$383
+14%
Analysts
24
Buy
Range
$340–$420
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $23.6B | $2.6B | $3.5B |
| 2024 | $23.1B | $2.7B | $3.2B |
| 2023 | $23.1B | $2.4B | $3.5B |
| 2022 | $22.1B | $2.0B | $1.9B |
| 2021 | $19.9B | $1.9B | $2.2B |
| 2020 | $18.4B | $2.0B | $3.4B |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +2.1%.
Earnings
Next report: 2026-10-27 · before open · EPS est 3.69
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | 3.52 | 3.70 | +5.1% |
| 2026-04-28 | 2.27 | 2.35 | +3.6% |
| 2026-01-29 | 2.16 | 2.23 | +3.1% |
| 2025-10-28 | 3.44 | 3.59 | +4.4% |
| 2025-07-22 | 3.81 | 3.38 | -11.2% |
| 2025-04-29 | 2.16 | 2.25 | +4.1% |
| 2025-01-30 | 2.06 | 2.09 | +1.6% |
| 2024-10-22 | 3.54 | 3.37 | -4.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $6.8B | +7.5% |
| 2026-03-31 | $5.7B | – |
| 2025-12-31 | $5.6B | – |
| 2025-09-30 | $6.4B | – |
| 2025-06-30 | $6.3B | – |
Analyst actions
Barclays
PT $348
2026-10-13 · init
→ Equal-WeightPT $348
RBC Capital
PT $392
2026-10-09 · main
Outperform → OutperformPT $392
UBS
PT $363
2026-10-05 · main
Neutral → NeutralPT $363
RBC Capital
PT $420
2026-09-25 · reit
Outperform → OutperformPT $420
Wells Fargo
PT $340
2026-09-25 · main
Equal-Weight → Equal-WeightPT $340
RBC Capital
PT $420
2026-09-22 · reit
Outperform → OutperformPT $420
Recent dividends
2026-08-21: $0.800 · 2026-05-22: $0.800 · 2026-03-02: $0.800 · 2025-11-14: $0.790 · 2025-08-15: $0.790 · 2025-05-16: $0.790 · 2025-03-03: $0.790 · 2024-11-15: $0.715
Insider trades
Binns Justin T
$4.8M
President, Glob. Architectural · 2026-08-17
SELL$4.8M
Jorgenrud Karl J
$2.9M
President, Glob. Industrial · 2026-08-07
SELL$2.9M
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 17:52:46 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.